Stem Cell Transplantation for Patients With Multiple Myeloma
Status:
Active, not recruiting
Trial end date:
2022-09-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether regulatory T-cell reduction is possible and safe
in myeloma subjects undergoing autologous stem cell transplantation (ASCT).